Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Novel urological agents disclosed in recent patent literature

March 21, 2006

ALK5 inhibitor a novel therapeutic approach for the treatment of fibrosis

March 20, 2006

TGF-beta1 gene-silencing treatment for progressive renal diseases

March 17, 2006

Intravenous and oral conivaptan raises serum sodium in heart failure patients

March 17, 2006

Enrollment completed in first of two phase III studies for Sanctura XR

March 9, 2006

Novel agents for nephritis disclosed in recent Shionogi patent

March 8, 2006

Clinical study of pollen extract preparation in CNBP/CPPS

March 6, 2006

Novel pathway involved in ADPKD identified / News in Context

March 3, 2006

Fast track status for tolvaptan in autosomal dominant polycystic kidney disease

Feb. 27, 2006

Keryx inlicenses novel phosphate binder Zerenex

Feb. 17, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...